ClinicalTrials.Veeva

Menu

The Analgesic Effect of Butorphanol After Cesarean Section

T

Tongji Hospital

Status

Unknown

Conditions

Analgesia

Treatments

Drug: butorphanol

Study type

Interventional

Funder types

Other

Identifiers

NCT04490980
TJ-C20200119

Details and patient eligibility

About

We evaluated the clinical effect of Butorphanol on postoperative analgesia by observing the vital signs of patients, general condition of newborns and pain assessment.

Enrollment

100 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Healthy women at term (37 to 42 weeks of gestation), who desired cesarean section were eligible to participate. undergoing ;No drug sensitive history

Exclusion criteria

Patients with a history of anesthetics allergy and patients with preterm labor, multiple pregnancies and severe obstetric complications

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

Observed group
Experimental group
Treatment:
Drug: butorphanol
Control group
No Intervention group

Trial contacts and locations

0

Loading...

Central trial contact

Xun Gong, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems